Sugemalimab plus chemotherapy versus chemotherapy for advanced gastric cancer in China: a cost-effectiveness analysis
Abstract This study aimed to evaluate the cost-effectiveness of sugemalimab plus chemotherapy compared to chemotherapy in the treatment of advanced gastric cancer in China. A Markov model of partitioned survival was developed based on the GEMSTONE-303 Phase III clinical trial evaluating sugemalimab...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Portfolio
2025-09-01
|
| Serie: | Scientific Reports |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1038/s41598-025-18030-w |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|